Is Biocure Technology Inc. (BICTF) a Buy, Sell, or Hold?
Biocure Technology Inc.
OTC:BICTF
$0.01 USD
$0 (0.0%)
- Volume
- 1K
- Average Volume
- 644
- Market Capitalization
- $379.09K
- P/E Ratio
- -2.10
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $0.07
- Year Low
- $0.01
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.10
| Source | Headline |
|---|---|
|
Biocure Technology Inc. Announces Adoption of Semi-Annual Reporting
Vancouver, B.C. – TheNewswire - May 8, 2026 ‐ Biocure Technology Inc. (CSE: CURE) (OTCQB: BICTF) (the “ Company” or “Biocure”) announces the adoption of semi-annual financial reporting. This news release is being filed pursuant to Coordinated Blanket Order 51 – 933 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers (“ CBO 51-933 ”). CBO 51-933 allows eligible venture issuers to voluntarily move from a quarterly to a semi-annual financial reporting framework. Biocure's fiscal year ends on December 31. Under the provisions of CBO 51-933, Biocure will be exempt from the requirements to file its three-month interim financial statements and associated management's discussion and analysis (“ MD&A ”) as it meets the eligibility criteria under CBO 51-933, which include being a venture issuer with annual revenues of less than $10 million and maintaining a clean 12-month continuous disclosure record. Accordingly, Biocure will not be filing its interim financial statements for the three-month period ending March 31, 2026 and associated MD&A. thenewswire.com - 2026-05-08 16:15:00 |
